Advertisement

Topics

Latest "Diagnostic Arthroscopy With Possible Debridement Surgical Intervention Tennis" News Stories

05:36 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Diagnostic Arthroscopy With Possible Debridement Surgical Intervention Tennis" found in our extensive news archives from over 250 global news sources.

More Information about Diagnostic Arthroscopy With Possible Debridement Surgical Intervention Tennis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Diagnostic Arthroscopy With Possible Debridement Surgical Intervention Tennis for you to read. Along with our medical data and news we also list Diagnostic Arthroscopy With Possible Debridement Surgical Intervention Tennis Clinical Trials, which are updated daily. BioPortfolio also has a large database of Diagnostic Arthroscopy With Possible Debridement Surgical Intervention Tennis Companies for you to search.

Showing "Diagnostic Arthroscopy With Possible Debridement Surgical Intervention Tennis" News Articles 1–25 of 6,400+

Friday 22nd February 2019

Global Obesity Surgery Devices Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Obesity Surgery Devices market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included based on ma...


Notice of Nexstim Plc 2018 Full Year Results

Company announcement, Helsinki, 22.02.2019 at 9am (EET)Notice of Nexstim Plc 2018 Full Year Results Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depression Disorder (MDD), will announce...

Thursday 21st February 2019

Global Dental Microscope Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Dental Microscope market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included based on manufact...


Ocular Therapeutix™ Prices $37.5 Million Subordinated Convertible Debt Financing

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it has entered into a note purchase agreement with an accredited investor to issue $37.5 million aggregate principal amount of 6.00% subor...

[Articles] Anal incontinence after caesarean and vaginal delivery in Sweden: a national population-based study

The risk of developing anal incontinence increases after pregnancy and delivery. Women with known risk factors for anal incontinence should perhaps be offered a more qualified post-partum examination to enable early intervention in case of injury. Further knowledge for optimal management are needed.

Progenity Announces Expansion of Board of Directors

Company Focused on Diagnostic and Therapeutic Precision Medicine Solutions in Prenatal and Perinatal Healthcare, Oncology, and Gastroenterology Progenity, Inc., a privately held biotechnology company, today announced the expansion of its board of directors with four new directors to support the company as it executes its plans to develop and com...

Covalon Announces Conference Call to Discuss First Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2019 First Quarter financial results on Tuesday February 26th, 2019, after markets close. A conference call to discuss the financial results will be held Wednesday February 27th, 2019, ...

STAAR Surgical Reports Fourth Quarter and Full Year 2018 Results

Fourth Quarter ICL Sales Rise 41%; Full Year 2018 ICL Sales Rise 48% GAAP Net Income of $0.02 Per Share in Fourth Quarter; $0.11 Per Share for Full Year 2018 STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial res...

How are interventional radiology/diagnostic radiology programs recruiting students?

ICON Acquires Precision Medicine for Oncology Company MolecularMD

ICON, a global provider of drug development solutions and services has acquired MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology. The acquisition of MolecularMD’s extensive scientific and clinical biomarker experience expands the ICON’s capabilities in molecular diagnostic testing and also adds expand...

This Month, SCMR Reminds Everyone that CMR Helps Get to the “Heart” of Cardiac Health

The Society for Cardiovascular Magnetic Resonance helps the public understand the value of using heart MRIs MOUNT ROYAL, N.J. (PRWEB) February 21, 2019 The Society for Cardiovascular Magnetic Resonance (SCMR), a Society dedicated to improving cardiovascular health by advancing the field of cardiovascular magnetic resonance (CMR), reminds the public not only that February is American Heart Month, ...

Catalent Appoints Kay Schmidt to Executive Leadership Team to Lead New Technical Operations Organization

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the appointment of Kay Schmidt as Senior Vice President, Technical Operations. In this new role, Ms. Schmidt will lead a team dedicated to continuously improving the technical and operational excellence that enables Ca...

Special Learning Is Very Proud to Add Colleen Anderson to Its Global Team as Director of Community Outreach

As the global autism prevalence rate continues to swell, nearly 70 million parents of children with autism stand helplessly by, as the sands of time takes away their child's ability to attain independence and higher quality of life because they lack access to a life-altering Autism intervention called Applied Behavior Analysis (ABA). CHICAGO (PRWEB) February 21, 2019 In the U.S. alone, accord...

Ultivue Expands Global Presence with Opening of European Subsidiary, Ultivue EMEA Srl

Ultivue, a developer of tissue biomarker identification and quantification assays for pathology and translational research labs, today announced that it has expanded its commercial footprint with a wholly-owned European subsidiary and appointed Luigi Pirovano as General Manager. Mr. Pirovano is an international executive with significant experience managin...

Factors associated with increased risk of developing surgical site infections

In an International Wound Journal study of 4,818 older patients undergoing elective orthopedic surgeries, five risk factors were linked with an increased risk of developing surgical site infections, including diabetes, morbid obesity, tobacco smoking, prolonged surgical duration, and lower serum albumin levels prior to surgery.

Hoopes Vision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

Phillip C. Hoopes, Jr., M.D. and Majid Moshirfar, M.D. at Hoopes Vision in Draper, Utah, are participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts. “As a clinical study site, we at Hoopes Vision are able to give our patients access to the most cutting-edge treatment options for ...

LivaNova’s Perceval Sutureless Aortic Heart Valve Receives National Reimbursement in Japan to Treat Patients with Aortic Valve Disease

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that Japan’s Ministry of Health, Labour and Welfare granted national reimbursement for the Company’s Perceval® sutureless aortic heart valve to treat aortic valve disease. By adding Perceval into Japan’s health insurance system, physicians and patients have grea...

Know Labs Bio-RFID™ Platform Technology Identifies Blood Alcohol Levels

Know Labs, Inc. (OTCQB:KNWN) – a provider of diagnostic solutions, released today a video presentation of its Bio-RFID™ platform technology’s successful identification of blood alcohol levels. In the video presentation, CEO Phil Bosua not only discusses the Company’s use of Bio-RFID to detect blood alcohol levels, but the broad implications for its...

Spacelabs Healthcare Receives $8 Million Order for Monitoring and Telemetry Upgrade Project

Spacelabs Healthcare (“Spacelabs” or the “Company”) today announced that it has been selected to complete a whole-house replacement of patient monitoring and telemetry equipment at a Level I Trauma Center in the western U.S. The project spans 43 departments and includes Spacelabs’ central stations, high-acuity bedside and transport monitors, as well as ...

Stratasys Brings Full-Color Digital Dental Impressions to Life

J720 Dental 3D Printer sets new standard in laboratory 3D Printing, combining accuracy, multi-material and full color functionality – at 1.75x throughput LMT LAB DAY CHICAGO – Injecting new levels of 3D printed realism into the dental industry, the new Stratasys (NASDAQ: SSYS) J720 Dental creates faster turnaround times so dental l...

New Virta Health Results Add Improved Sleep as Benefit of the Virta Treatment

Emerging Evidence Suggests that Sleep Quality Improves with Virta Health’s Novel Care Model and Intervention for Type 2 Diabetes Reversal Virta Health, the first company with a treatment to safely and sustainably reverse type 2 diabetes (T2D) without the use of medications or surgery, today announced the publication of new peer-reviewed research in

UroGen Pharma to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 28, 2019

Conference Call and Webcast Scheduled for 8:30 AM ET UroGen Pharma Ltd. (Nasdaq:URGN) today announced that it will report fourth quarter and full year 2018 financial results on Thursday, February 28, 2019, prior to the open of the market. The announcement will be followed by a live audio webcast and conference call at 8:30AM Eastern Time. ...

HSTpathways CEO Tom Hui to Speak at 14th Annual KeyBanc Capital Markets Emerging Technology Summit

Ambulatory Surgery Center Industry Leader Shares Best Practices in Healthcare Clinical Efficiency & Communications HSTpathways CEO and founder

Abatacept and Joint Surgery: The Best Time to Stop? (CME/CE)

(MedPage Today) -- Pre-surgical biologic hold for one dosing interval not tied to lower risk of hospitalized infection, other outcomes

Psychosis May Accelerate Brain Aging

Accelerated aging of cognitive networks after psychosis onset may offer the potential for early intervention in patients with schizophrenia or bipolar disorder, new research suggests. Medscape Medical News


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks